NPI 1861689531: Open Payments
NPI 1861689531. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$101 in 5 payments from 5 companies in 2025. Trend: 2023 $423 · 2024 $78 · 2025 $101
Food & beverage: $101
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $25 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: VERQUVO, Quviviq, Flexitouch Plus, UBRELVY, LEQVIO.
